willdate

28 POSTS 0 COMMENTS

Philips launches Azurion neuro biplane system

azurion neuro
Royal Philips has announced major enhancements to its image-guided therapy system—Azurion—with the launch of its new Azurion neuro biplane system. Featuring enhanced imaging and gantry...

GE HealthCare to acquire AI-imaging specialist

GE HealthCare has entered into an agreement to acquire MIM Software, a provider of artificial intelligence (AI)-enabled image analysis and workflow tools across multiple...

Kaneka Corporation acquires Japan Medical Device Technology

Kaneka Corporation has acquired all shares of Japan Medical Device Technology and has made it a wholly owned subsidiary. Kaneka manufactures and sells endovascular catheters,...

Mount Sinai neurointerventionist J Mocco joins Protembis board of directors

Protembis has announced the appointment of J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) as an independent member of its...

UK MHRA adds capacity for medical device certification

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has designated three new approved bodies to increase the country’s capacity to certify medical devices. TÜV...

US FDA seeks to “modernise” clinical trials with new draft guidance

The US Food and Drug Administration (FDA) has released draft guidance with updated recommendations for good clinical practices (GCPs) aimed at modernising the design...

EU ministers approve changes to MDR transition timetable

The European Union’s (EU) Council of Ministers has today adopted a resolution to extend the deadline for the certification of medical devices under the...

Barostim neuromodulation device misses primary endpoint in BEAT-HF trial

CVRx has announced the preliminary topline results of the BEAT-HF (Baroreflex activation therapy for heart failure) postmarket clinical trial. The BEAT-HF postmarket phase of the...

Corindus rebrands to Siemens Healthineers Endovascular Robotics

Corindus has been rebranded to Siemens Healthineers Endovascular Robotics and will sit as a dedicated business within the Advanced Therapies area of Siemens Healthineers,...

EU Commission to propose delay to MDR implementation

Europe’s health commissioner, Stella Kyriakides, has announced that proposals to extend the transition period for the implementation of the European Union’s (EU) Medical Device...

TCT 2022: No difference in rates of post-TAVI stroke seen with...

Among patients undergoing transfemoral transcatheter aortic valve implantation (TAVI), the use of a cerebral embolic protection device (Sentinel, Boston Scientific) did not have a...

FDA clears Viz.ai’s RV/LV ratio algorithm

Viz.ai has received US Food and Drug Administration (FDA) 510(k) clearance for an automated right ventricle-to-left ventricle (RV/LV) ratio algorithm, a new component of...

Medtronic expands reach of AI-powered surgical video management and analytics platform

Medtronic has announced that it has entered into a contract with Vizient to add Touch Surgery Enterprise, an AI-powered surgical video management and analytics...

Medtronic announces 2045 net zero emissions ambition to combat climate change

Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across its operations and value chain to accelerate efforts...

Study highlights temporal relationship between atrial fibrillation and stroke

Medtronic has announced the publication of a study demonstrating, through the use of a continuous rhythm monitoring device, that atrial fibrillation (AF) is directly...

With you all the way

  Stroke care has seen considerable advances in recent years, and Stryker Neurovascular has played a role in these developments. In addition to expanding its...

MDR comes into effect across EU

The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021). The Regulation revises quality and safety standards and the range...

CX 2021 poll sees thrombolysis trump endovascular treatment in basilar artery...

A series of debates tested expert response to current acute stroke controversies during the final day of the Charing Cross (CX) 2021 Digital Edition...

Evolution of radial access in the neurovascular space

This advertorial is sponsored by Medtronic The field of neurointervention has seen a dramatic increase in the adoption of radial artery access over the past...

Terumo reaches agreement to acquire predictive analytics specialist Health Outcomes Sciences

Terumo Corporation has signed a definitive agreement to acquire all assets of Health Outcomes Sciences, a specialist in predictive analytics and clinical decision support...

Coil pliability matters: Novel metrics for assessment of in vitro coil...

This advertorial is sponsored by Medtronic Neurovascular The deployment of an embolisation coil is “much more art than science” according to Daniel Sahlein (Goodman Campbell...

NeuroNews Issue 39 – US Edition

Highlights: Comprehensive coverage from the Society of NeuroInterventional Surgery (SNIS) 17th Annual meeting (4–7 August) including two new studies to describe outcome-related racial disparities...

NeuroNews Issue 39

Highlights: Comprehensive coverage from the Society of NeuroInterventional Surgery (SNIS) 17th Annual meeting (4–7 August) including two new studies to describe outcome-related racial disparities...

Stroke treatment in the fast lane

The last five years have seen endovascular therapy for patients with acute ischaemic stroke proven undeniably effective, changing the face of stroke treatment forever. While...

Stryker develops Emergency Relief Bed in response to COVID-19 pandemic

Stryker has announced the development of a limited-release emergency response bed to quickly aid healthcare providers with efficient care during the COVID-19 pandemic. The Emergency...

AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research

The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...

Neuroprotective drug elicits beneficial effects in the 40% of patients who...

The final results of the ESCAPE-NA1 trial have been presented and published contemporaneously in The Lancet. The study investigated the safety and efficacy of...

GTX Medical and NeuroRecovery Technologies announce merger

GTX Medical (formerly G-Therapeutics) and NeuroRecovery Technologies (NRT) have announced a merger, creating a global company for the development of neuromodulation therapies to aid...